`571-272-7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper 48
`
`
` Date: February 17, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`LIQUIDIA TECHNOLOGIES, INC.,
`Petitioner,
`
`v.
`
`UNITED THERAPEUTICS CORPORATION,
`Patent Owner.
`____________
`
`IPR2020-00770
`Patent 9,604,901 B2
`____________
`
`
`
`Before ANDREW HIRSHFELD, Commissioner for Patents, Performing the
`Functions and Duties of the Under Secretary of Commerce for Intellectual
`Property and Director of the United States Patent and Trademark Office,
`SCOTT R. BOALICK, Chief Administrative Patent Judge, and
`JACQUELINE WRIGHT BONILLA, Deputy Chief Administrative Patent
`Judge.
`
`
`PER CURIAM.
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-00770
`Patent 9,604,901 B2
`
`
`ORDER
`
`The Office received a rehearing request and a request for Precedential
`Opinion Panel (POP) review of an issue raised in this case. See Paper 46;
`Ex. 3002. The requests were referred to the POP panel referenced above.
`Upon consideration of the requests, it is:
`ORDERED that the request for POP review is denied; and
`FURTHER ORDERED that the original panel maintains authority
`over all matters, including considering the submitted rehearing request.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`IPR2020-00770
`Patent 9,604,901 B2
`
`FOR PETITIONER:
`Ivor R. Elrifi
`Erik B. Milch
`Cooley LLP
`ielrifi@cooley.com
`emilch@cooley.com
`
`
`FOR PATENT OWNER:
`Stephen B. Maebius
`George Quillin
`Daniel R. Shelton
`Foley & Lardner LLP
`smaebius@foley.com
`gquillin@foley.com
`dshelton@foley.com
`
`Shaun R. Snader
`United Therapeutics Corp.
`ssnader@unither.com
`
`Douglas Carsten
`Richard Torczon
`Wilson, Sonsini, Goodrich & Rosati
`dcarsten@wsgr.com
`rtorczon@wsgr.com
`
`
`
`3
`
`